These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3563583)

  • 41. Low dose spironolactone in the treatment of female hyperandrogenemia and hirsutism.
    Vĕtr M; Sobek A
    Acta Univ Palacki Olomuc Fac Med; 1993; 135():55-7. PubMed ID: 7976677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic alternatives for the hirsute woman.
    Bassaw B; Maharaj R; Ali A; Roopnarinesingh S
    West Indian Med J; 1992 Mar; 41(1):12-4. PubMed ID: 1533080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute women.
    Givens JR; Andersen RN; Wiser WL; Umstot ES; Fish SA
    Am J Obstet Gynecol; 1976 Feb; 124(4):333-9. PubMed ID: 1251854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of spironolactone on hirsutism and female androgen metabolism.
    Dorrington-Ward P; McCartney AC; Holland S; Scully J; Carter G; Alaghband-Zadeh J; Wise P
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):161-7. PubMed ID: 4053414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
    Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
    Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement.
    Williams SR; Frenchek B; Speroff T; Speroff L
    Am J Obstet Gynecol; 1990 Feb; 162(2):438-46. PubMed ID: 2309827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spironolactone in the treatment of hirsutism.
    Chapman MG; Katz M; Dowsett M; Hague W; Jeffcoate SL; Dewhurst CJ
    Acta Obstet Gynecol Scand; 1986; 65(4):349-50. PubMed ID: 3739647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cyproterone acetate and spironolactone compared in the therapy of female hirsutism].
    Suraci C; Costa C; De Pedrini P
    Clin Ter; 1983 Mar; 104(6):463-7. PubMed ID: 6221860
    [No Abstract]   [Full Text] [Related]  

  • 50. The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters.
    Parr JH; Seed M; Godsland I; Wynn V
    J Endocrinol Invest; 1987 Jun; 10(3):237-9. PubMed ID: 2957418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The treatment of hirsutism in adolescent girls with spironolactone].
    Malinova M
    Akush Ginekol (Sofiia); 1999; 38(4):28-30. PubMed ID: 10726349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.
    Reisman H; Martin D; Gast MJ
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):45-52. PubMed ID: 10561675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of flutamide versus spironolactone.
    Erenus M
    Fertil Steril; 1995 Mar; 63(3):680. PubMed ID: 7851609
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of hirsutism with spironolactone and with spironolactone plus dexamethasone].
    Devoto E; Aravena L; Ríos R
    Rev Med Chil; 2000 Aug; 128(8):868-75. PubMed ID: 11129548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hirsutism and the effect of treatment with oestrogens.
    Duignan NM
    Ir Med J; 1977 Aug; 70(12):364-7. PubMed ID: 561040
    [No Abstract]   [Full Text] [Related]  

  • 57. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prevention of recurrent hemorrhages in Rendu-Osler's disease by estrogen-progestative treatment].
    Li V; Salvat J; Hostein J
    Gastroenterol Clin Biol; 1992; 16(3):292. PubMed ID: 1582551
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
    O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
    J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of hirsutism with spironolactone and progestagen combination].
    Pugeat M; Elmidani M; Dechaud H; Garoscio-Cholet M; Lejeune H; Tourniaire J
    Presse Med; 1990 Oct; 19(33):1529-32. PubMed ID: 2146664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.